Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore F Reiss

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Respiratory Medicine|February 4, 2012
Airway obstruction lability helps distinguish levels of disease activity in asthmaSteven Greenberg, Nancy Liu, Amarjot Kaur, et al.
Contemporary Clinical Trials|September 12, 2025
Design of RESOLVE Lung, a multinational Phase 2, randomized, placebo-controlled trial of the anti-GM-CSF monoclonal antibody namilumab in patients with chronic pulmonary sarcoidosisBernt van den Blink, Chantal M Petit, Hayes M Dansky, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 31, 2004
Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studiesPaul Chervinsky, George Philip, Marie-Pierre Malice, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 13, 2006
Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitisPiyush Patel, George Philip, William Yang, et al.
American Journal of Respiratory and Critical Care Medicine|June 28, 2008
Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in childrenHans Bisgaard, Alejandro Flores-Nunez, Anne Goh, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 1, 2011
Intermittent or daily montelukast versus placebo for episodic asthma in childrenErkka Valovirta, Maria L Boza, Colin F Robertson, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 26, 2004
Protective effect of montelukast on lower and upper respiratory tract responses to short-term cat allergen exposureTamara T Perry, Jonathan Corren, George Philip, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2010
A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthmaCarlos A Camargo, Deborah M Gurner, Howard A Smithline, et al.
The Journal of Allergy and Clinical Immunology|October 6, 2012
The asthma disease activity score: a discriminating, responsive measure predicts future asthma attacksSteven Greenberg, Nancy Liu, Amarjot Kaur, et al.
American Journal of Respiratory and Critical Care Medicine|January 10, 2002
Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trialSven-Erik Dahlén, Kerstin Malmström, Ewa Nizankowska, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Respiratory Medicine|February 4, 2012
Airway obstruction lability helps distinguish levels of disease activity in asthmaSteven Greenberg, Nancy Liu, Amarjot Kaur, et al.
Contemporary Clinical Trials|September 12, 2025
Design of RESOLVE Lung, a multinational Phase 2, randomized, placebo-controlled trial of the anti-GM-CSF monoclonal antibody namilumab in patients with chronic pulmonary sarcoidosisBernt van den Blink, Chantal M Petit, Hayes M Dansky, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 31, 2004
Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studiesPaul Chervinsky, George Philip, Marie-Pierre Malice, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 13, 2006
Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitisPiyush Patel, George Philip, William Yang, et al.
American Journal of Respiratory and Critical Care Medicine|June 28, 2008
Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in childrenHans Bisgaard, Alejandro Flores-Nunez, Anne Goh, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 1, 2011
Intermittent or daily montelukast versus placebo for episodic asthma in childrenErkka Valovirta, Maria L Boza, Colin F Robertson, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 26, 2004
Protective effect of montelukast on lower and upper respiratory tract responses to short-term cat allergen exposureTamara T Perry, Jonathan Corren, George Philip, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2010
A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthmaCarlos A Camargo, Deborah M Gurner, Howard A Smithline, et al.
The Journal of Allergy and Clinical Immunology|October 6, 2012
The asthma disease activity score: a discriminating, responsive measure predicts future asthma attacksSteven Greenberg, Nancy Liu, Amarjot Kaur, et al.
American Journal of Respiratory and Critical Care Medicine|January 10, 2002
Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trialSven-Erik Dahlén, Kerstin Malmström, Ewa Nizankowska, et al.
Pageof 6